United States DPP IV Inhibitor Market Report 2016

September 2016 | 120 pages | ID: UA786A1A6D2EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of DPP IV Inhibitor

Revenue, means the sales value of DPP IV Inhibitor

This report studies sales (consumption) of DPP IV Inhibitor in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• AstraZeneca Plc. (UK)
• Boehringer Ingelheim GmbH (Germany)
• Eli Lilly and Company (US)
• Merck & Co, Inc. (US)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Novartis AG (Switzerland)
• Takeda Pharmaceutical Company Limited (Japan)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of DPP IV Inhibitor in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States DPP IV Inhibitor Market Report 2016

1 DPP IV INHIBITOR OVERVIEW

1.1 Product Overview and Scope of DPP IV Inhibitor
1.2 Classification of DPP IV Inhibitor
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of DPP IV Inhibitor
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of DPP IV Inhibitor (2011-2021)
  1.4.1 United States DPP IV Inhibitor Sales and Growth Rate (2011-2021)
  1.4.2 United States DPP IV Inhibitor Revenue and Growth Rate (2011-2021)

2 UNITED STATES DPP IV INHIBITOR COMPETITION BY MANUFACTURERS

2.1 United States DPP IV Inhibitor Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States DPP IV Inhibitor Revenue and Share by Manufactures (2015 and 2016)
2.3 United States DPP IV Inhibitor Average Price by Manufactures (2015 and 2016)
2.4 DPP IV Inhibitor Market Competitive Situation and Trends
  2.4.1 DPP IV Inhibitor Market Concentration Rate
  2.4.2 DPP IV Inhibitor Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES DPP IV INHIBITOR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States DPP IV Inhibitor Sales and Market Share by Type (2011-2016)
3.2 United States DPP IV Inhibitor Revenue and Market Share by Type (2011-2016)
3.3 United States DPP IV Inhibitor Price by Type (2011-2016)
3.4 United States DPP IV Inhibitor Sales Growth Rate by Type (2011-2016)

4 UNITED STATES DPP IV INHIBITOR SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States DPP IV Inhibitor Sales and Market Share by Application (2011-2016)
4.2 United States DPP IV Inhibitor Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES DPP IV INHIBITOR MANUFACTURERS PROFILES/ANALYSIS

5.1 AstraZeneca Plc. (UK)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 DPP IV Inhibitor Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 AstraZeneca Plc. (UK) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Boehringer Ingelheim GmbH (Germany)
  5.2.2 DPP IV Inhibitor Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Boehringer Ingelheim GmbH (Germany) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Eli Lilly and Company (US)
  5.3.2 DPP IV Inhibitor Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Eli Lilly and Company (US) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Merck & Co, Inc. (US)
  5.4.2 DPP IV Inhibitor Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Merck & Co, Inc. (US) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Mitsubishi Tanabe Pharma Corporation (Japan)
  5.5.2 DPP IV Inhibitor Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Mitsubishi Tanabe Pharma Corporation (Japan) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Novartis AG (Switzerland)
  5.6.2 DPP IV Inhibitor Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Novartis AG (Switzerland) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Takeda Pharmaceutical Company Limited (Japan)
  5.7.2 DPP IV Inhibitor Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Takeda Pharmaceutical Company Limited (Japan) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview

6 DPP IV INHIBITOR MANUFACTURING COST ANALYSIS

6.1 DPP IV Inhibitor Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of DPP IV Inhibitor

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 DPP IV Inhibitor Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of DPP IV Inhibitor Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES DPP IV INHIBITOR MARKET FORECAST (2016-2021)

10.1 United States DPP IV Inhibitor Sales, Revenue Forecast (2016-2021)
10.2 United States DPP IV Inhibitor Sales Forecast by Type (2016-2021)
10.3 United States DPP IV Inhibitor Sales Forecast by Application (2016-2021)
10.4 DPP IV Inhibitor Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of DPP IV Inhibitor
Table Classification of DPP IV Inhibitor
Figure United States Sales Market Share of DPP IV Inhibitor by Type in 2015
Table Application of DPP IV Inhibitor
Figure United States Sales Market Share of DPP IV Inhibitor by Application in 2015
Figure United States DPP IV Inhibitor Sales and Growth Rate (2011-2021)
Figure United States DPP IV Inhibitor Revenue and Growth Rate (2011-2021)
Table United States DPP IV Inhibitor Sales of Key Manufacturers (2015 and 2016)
Table United States DPP IV Inhibitor Sales Share by Manufacturers (2015 and 2016)
Figure 2015 DPP IV Inhibitor Sales Share by Manufacturers
Figure 2016 DPP IV Inhibitor Sales Share by Manufacturers
Table United States DPP IV Inhibitor Revenue by Manufacturers (2015 and 2016)
Table United States DPP IV Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States DPP IV Inhibitor Revenue Share by Manufacturers
Table 2016 United States DPP IV Inhibitor Revenue Share by Manufacturers
Table United States Market DPP IV Inhibitor Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market DPP IV Inhibitor Average Price of Key Manufacturers in 2015
Figure DPP IV Inhibitor Market Share of Top 3 Manufacturers
Figure DPP IV Inhibitor Market Share of Top 5 Manufacturers
Table United States DPP IV Inhibitor Sales by Type (2011-2016)
Table United States DPP IV Inhibitor Sales Share by Type (2011-2016)
Figure United States DPP IV Inhibitor Sales Market Share by Type in 2015
Table United States DPP IV Inhibitor Revenue and Market Share by Type (2011-2016)
Table United States DPP IV Inhibitor Revenue Share by Type (2011-2016)
Figure Revenue Market Share of DPP IV Inhibitor by Type (2011-2016)
Table United States DPP IV Inhibitor Price by Type (2011-2016)
Figure United States DPP IV Inhibitor Sales Growth Rate by Type (2011-2016)
Table United States DPP IV Inhibitor Sales by Application (2011-2016)
Table United States DPP IV Inhibitor Sales Market Share by Application (2011-2016)
Figure United States DPP IV Inhibitor Sales Market Share by Application in 2015
Table United States DPP IV Inhibitor Sales Growth Rate by Application (2011-2016)
Figure United States DPP IV Inhibitor Sales Growth Rate by Application (2011-2016)
Table AstraZeneca Plc. (UK) Basic Information List
Table AstraZeneca Plc. (UK) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Plc. (UK) DPP IV Inhibitor Sales Market Share (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) DPP IV Inhibitor Sales Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (US) DPP IV Inhibitor Sales Market Share (2011-2016)
Table Merck & Co, Inc. (US) Basic Information List
Table Merck & Co, Inc. (US) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co, Inc. (US) DPP IV Inhibitor Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) DPP IV Inhibitor Sales Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG (Switzerland) DPP IV Inhibitor Sales Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) DPP IV Inhibitor Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of DPP IV Inhibitor
Figure Manufacturing Process Analysis of DPP IV Inhibitor
Figure DPP IV Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of DPP IV Inhibitor Major Manufacturers in 2015
Table Major Buyers of DPP IV Inhibitor
Table Distributors/Traders List
Figure United States DPP IV Inhibitor Production and Growth Rate Forecast (2016-2021)
Figure United States DPP IV Inhibitor Revenue and Growth Rate Forecast (2016-2021)
Table United States DPP IV Inhibitor Production Forecast by Type (2016-2021)
Table United States DPP IV Inhibitor Consumption Forecast by Application (2016-2021)